Advanced search
1 file | 251.34 KB Add to list

Characteristics of long-term survival in advanced stage ovarian cancer : a nationwide cohort in the Netherlands

Author
Organization
Abstract
Objective: Despite optimal treatment with debulking surgery and chemotherapy, the majority of patients with advanced stage epithelial ovarian cancer (EOC) die within five years. Survival beyond eight years is rare and the mechanisms that lead to such favorable outcomes are incompletely understood. We aimed to identify characteristics associated with long-term survival (LTS) in a population-based cohort of patients with advanced stage EOC. Methods: Patients with advanced stage (FIGO IIB-IV) EOC diagnosed between 2008 and 2012 were identified from the Netherlands Cancer Registry. LTS was defined as survival for more than eight years after diagnosis, based on 20% survival within this cohort. Patient, tumor, and treatment characteristics were analyzed using multivariable logistic regression to find predictors for LTS. Results: We identified 2744 eligible patients of whom 571 were long-term survivors (survival longer than eight years). Younger age, lower tumor stage, low-grade histology, FIGO IV based on extra-abdominal lymph node compared to pleural metastasis, primary debulking surgery vs neo-adjuvant chemotherapy followed by interval debulking surgery, residual disease less than one cm or no macroscopic disease, and ascites less than 100 mL were associated with LTS. Furthermore, less than six chemotherapy cycles compared to six, and carboplatin plus paclitaxel combined with other chemotherapy agents compared to carboplatin plus paclitaxel, were associated with a lower odds of LTS. Conclusion: Characteristics of the tumor, patient and treatment play a substantial role in respect to the prognosis of advanced stage EOC, and can assist in the prediction of LTS.
Keywords
Obstetrics and Gynecology, Oncology, Long-term survivor, Epithelial ovarian cancer, Prognostic factors, Cancer survivors, PROGNOSTIC-FACTORS, GYNECOLOGIC-ONCOLOGY, CHEMOTHERAPY, PACLITAXEL, PREDICTION, MORTALITY, CARCINOMA, SURGERY, CYCLES

Downloads

  • 2022 van Wagensveld Lilian.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 251.34 KB

Citation

Please use this url to cite or link to this publication:

MLA
van Wagensveld, Lilian, et al. “Characteristics of Long-Term Survival in Advanced Stage Ovarian Cancer : A Nationwide Cohort in the Netherlands.” EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol. 43, no. 1, 2022, pp. 1–9, doi:10.31083/j.ejgo4301007.
APA
van Wagensveld, L., Sonke, G. S., Van de Vijver, K., Horlings, H. M., Kruitwagen, R. F. P. M., & van der Aa, M. A. (2022). Characteristics of long-term survival in advanced stage ovarian cancer : a nationwide cohort in the Netherlands. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 43(1), 1–9. https://doi.org/10.31083/j.ejgo4301007
Chicago author-date
Wagensveld, Lilian van, Gabe Steven Sonke, Koen Van de Vijver, Hugo Mark Horlings, Rutgerus Franciscus Petrus Maria Kruitwagen, and Maaike Anne van der Aa. 2022. “Characteristics of Long-Term Survival in Advanced Stage Ovarian Cancer : A Nationwide Cohort in the Netherlands.” EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 43 (1): 1–9. https://doi.org/10.31083/j.ejgo4301007.
Chicago author-date (all authors)
van Wagensveld, Lilian, Gabe Steven Sonke, Koen Van de Vijver, Hugo Mark Horlings, Rutgerus Franciscus Petrus Maria Kruitwagen, and Maaike Anne van der Aa. 2022. “Characteristics of Long-Term Survival in Advanced Stage Ovarian Cancer : A Nationwide Cohort in the Netherlands.” EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 43 (1): 1–9. doi:10.31083/j.ejgo4301007.
Vancouver
1.
van Wagensveld L, Sonke GS, Van de Vijver K, Horlings HM, Kruitwagen RFPM, van der Aa MA. Characteristics of long-term survival in advanced stage ovarian cancer : a nationwide cohort in the Netherlands. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 2022;43(1):1–9.
IEEE
[1]
L. van Wagensveld, G. S. Sonke, K. Van de Vijver, H. M. Horlings, R. F. P. M. Kruitwagen, and M. A. van der Aa, “Characteristics of long-term survival in advanced stage ovarian cancer : a nationwide cohort in the Netherlands,” EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol. 43, no. 1, pp. 1–9, 2022.
@article{8753422,
  abstract     = {{Objective: Despite optimal treatment with debulking surgery and chemotherapy, the majority of patients with advanced stage epithelial ovarian cancer (EOC) die within five years. Survival beyond eight years is rare and the mechanisms that lead to such favorable outcomes are incompletely understood. We aimed to identify characteristics associated with long-term survival (LTS) in a population-based cohort of patients with advanced stage EOC. Methods: Patients with advanced stage (FIGO IIB-IV) EOC diagnosed between 2008 and 2012 were identified from the Netherlands Cancer Registry. LTS was defined as survival for more than eight years after diagnosis, based on 20% survival within this cohort. Patient, tumor, and treatment characteristics were analyzed using multivariable logistic regression to find predictors for LTS. Results: We identified 2744 eligible patients of whom 571 were long-term survivors (survival longer than eight years). Younger age, lower tumor stage, low-grade histology, FIGO IV based on extra-abdominal lymph node compared to pleural metastasis, primary debulking surgery vs neo-adjuvant chemotherapy followed by interval debulking surgery, residual disease less than one cm or no macroscopic disease, and ascites less than 100 mL were associated with LTS. Furthermore, less than six chemotherapy cycles compared to six, and carboplatin plus paclitaxel combined with other chemotherapy agents compared to carboplatin plus paclitaxel, were associated with a lower odds of LTS. Conclusion: Characteristics of the tumor, patient and treatment play a substantial role in respect to the prognosis of advanced stage EOC, and can assist in the prediction of LTS.}},
  author       = {{van Wagensveld, Lilian and Sonke, Gabe Steven and Van de Vijver, Koen and Horlings, Hugo Mark and Kruitwagen, Rutgerus Franciscus Petrus Maria and van der Aa, Maaike Anne}},
  issn         = {{0392-2936}},
  journal      = {{EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY}},
  keywords     = {{Obstetrics and Gynecology,Oncology,Long-term survivor,Epithelial ovarian cancer,Prognostic factors,Cancer survivors,PROGNOSTIC-FACTORS,GYNECOLOGIC-ONCOLOGY,CHEMOTHERAPY,PACLITAXEL,PREDICTION,MORTALITY,CARCINOMA,SURGERY,CYCLES}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{1--9}},
  title        = {{Characteristics of long-term survival in advanced stage ovarian cancer : a nationwide cohort in the Netherlands}},
  url          = {{http://doi.org/10.31083/j.ejgo4301007}},
  volume       = {{43}},
  year         = {{2022}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: